Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo

MIR143 is pathologically downregulated and may function as a tumor suppressor in prostate cancer. Likewise, the urokinase plasminogen activator receptor (UPAR) is overexpressed in prostate carcinoma, representing a negative prognostic marker and putative therapeutic target gene. In this paper, we es...

Descripción completa

Detalles Bibliográficos
Autores principales: Wach, Sven, Brandl, Madeleine, Borchardt, Hannes, Weigelt, Katrin, Lukat, Sabine, Nolte, Elke, Al-Janabi, Omar, Hart, Martin, Grässer, Friedrich, Giedl, Johannes, Jung, Rudolf, Stöhr, Robert, Hartmann, Arndt, Lieb, Verena, Höbel, Sabrina, Peters, Anna, Stäubert, Claudia, Wullich, Bernd, Taubert, Helge, Aigner, Achim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444223/
https://www.ncbi.nlm.nih.gov/pubmed/30933831
http://dx.doi.org/10.1016/j.omtn.2019.02.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444223/
https://www.ncbi.nlm.nih.gov/pubmed/30933831
http://dx.doi.org/10.1016/j.omtn.2019.02.020

Ejemplares similares